Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	23.08	15.7	10.48	34.67	51.67	4.67
Cash & Short-Term Investments	23.08	15.7	10.48	34.67	51.67	4.67
Cash Growth	105.43%	49.85%	-69.78%	-32.91%	1006.64%	-2.31%
Other Receivables	0.37	0.23	0.95	1.7	1.15	0.46
Receivables	0.37	0.23	0.95	1.7	1.15	0.46
Prepaid Expenses	1.51	2.52	6.12	6.67	2.48	1.85
Other Current Assets	0.05	-	-	-	-	-
Total Current Assets	25	18.45	17.54	43.04	55.3	6.98
Property, Plant & Equipment	4.73	2.54	1.98	0.52	0.24	0.28
Long-Term Deferred Charges	-	-	-	-	0.14	-
Other Long-Term Assets	1.02	1.11	1.76	0.26	0.13	0.29
Total Assets	30.75	22.1	21.28	43.83	55.81	7.55
Accounts Payable	1.84	1.46	3.39	2.03	2.1	1.02
Accrued Expenses	2.32	3.04	2.89	10.89	3.14	3.36
Short-Term Debt	-	-	-	-	-	0.37
Current Portion of Leases	2.48	0.55	0.47	0.4	0.27	0.35
Current Unearned Revenue	14.56	16.56	13.74	18.3	10.54	1.56
Other Current Liabilities	0.01	-	-	-	-	1
Total Current Liabilities	21.22	21.61	20.48	31.62	16.05	7.66
Long-Term Leases	0.45	0.75	0.94	0.09	-	0.04
Long-Term Unearned Revenue	6.22	5.75	4.91	1	1	1
Total Liabilities	27.89	28.11	26.33	32.71	17.05	8.7
Common Stock	0	0	0	0.01	0.01	0
Additional Paid-In Capital	190.5	169.71	166.55	152.53	149.03	70.37
Retained Earnings	-187.25	-175.29	-171.24	-141.07	-110.13	-71.43
Comprehensive Income & Other	-0.4	-0.43	-0.36	-0.35	-0.15	-0.09
Shareholders' Equity	2.86	-6.01	-5.05	11.11	38.75	-1.15
Total Liabilities & Equity	30.75	22.1	21.28	43.83	55.81	7.55
Total Debt	2.93	1.3	1.4	0.49	0.27	0.76
Net Cash (Debt)	20.14	14.4	9.07	34.18	51.4	3.91
Net Cash Growth	104.93%	58.68%	-73.46%	-33.51%	1213.79%	-1.68%
Net Cash Per Share	2.10	1.69	1.25	4.85	10.09	1.56
Filing Date Shares Outstanding	14.29	8.85	8.38	7.18	7	3.94
Total Common Shares Outstanding	13.93	8.7	8.33	7.07	7	3.47
Working Capital	3.79	-3.16	-2.94	11.41	39.24	-0.68
Book Value Per Share	0.21	-0.69	-0.61	1.57	5.54	-0.33
Tangible Book Value	2.86	-6.01	-5.05	11.11	38.75	-1.15
Tangible Book Value Per Share	0.21	-0.69	-0.61	1.57	5.54	-0.33
Machinery	-	0.24	0.16	-	-	-
Construction In Progress	-	1.23	0.6	-	-	-
Leasehold Improvements	-	0.04	0.04	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q